Sophia Steigerwald
Sophia Steigerwald

Sophia Steigerwald

Graduate PhD student, Max Planck Institute for Biochemistry, DigiMed Bayern Consortium Partner

Sophia Steigerwald received her Bachelor's and Master of Science degrees from the Technical University Munich in Molecular Biotechnology and Biochemistry respectively. For her master thesis she worked in the Mass Spectrometry for Quantitative Proteomics Group at the Novo Nordisk Foundation Center for Protein Research under the supervision of Prof. Dr. Jesper Olsen on dynamic protein sub-cellular localization by mass spectrometry (MS) as well as MS technology. She is currently doing her PhD as an IMPRS graduate student at the Max Planck Institute for Biochemistry in Martinsried, Germany, were she works under the supervision of Prof. Dr. Matthias Mann. Her PhD research focuses on MS technology, method development and clinical proteomics in the context of cardiovascular diseases. As part of the DigiMed Bayern consortium, she works in close collaboration with the clinical consortium members to study disease-based differences in protein expression and to identify potential protein biomarkers.